Trials / Completed
CompletedNCT03735810
Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBS-008 in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- RBP4 Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a single center, randomized, double-blind, placebo-controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) study is planned to assess safety, pharmacokinetics (PK), and pharmacodynamics of LBS-008 in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LBS-008 | LBS-008 oral capsules |
| DRUG | Placebos | Oral capsules |
Timeline
- Start date
- 2018-11-15
- Primary completion
- 2019-09-16
- Completion
- 2019-09-16
- First posted
- 2018-11-08
- Last updated
- 2020-01-07
Locations
1 site across 1 country: Australia
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03735810. Inclusion in this directory is not an endorsement.